What are the treatment options for adenomyosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Adenomyosis

Medical management should be trialed as first-line therapy for adenomyosis before pursuing more invasive treatments. 1, 2

Medical Treatment Options

First-Line Options:

  • Non-hormonal treatments:

    • NSAIDs: First choice for pain control, can reduce bleeding by 20-40% 2, 3
    • Tranexamic acid: First-line non-hormonal medication for heavy menstrual bleeding, taken only during menstruation 2
      • Contraindicated in women with active thromboembolic disease or history of thrombosis
  • Hormonal treatments:

    • Progestin-containing IUDs (Levonorgestrel IUD/Mirena): Most effective hormonal option for bleeding control and pain relief 2, 3, 4
    • Combined oral contraceptives: Effective for controlling bleeding symptoms, especially with smaller lesions 2, 3
    • Progestins (e.g., dienogest, norethindrone acetate): Provide antiproliferative and anti-inflammatory effects, mainly for pain control 5, 3

Second-Line Options:

  • GnRH agonists: Effective for short-term use (3-6 months)

    • Reduces bleeding and lesion volume by 40-50% 2
    • Particularly indicated before fertility treatments to improve pregnancy chances in infertile women 5
    • Caution: Chronic use causes trabecular bone loss; add-back therapy recommended for extended use 2
  • Selective progesterone receptor modulators (SPRMs): Emerging treatment option 5, 4

  • Aromatase inhibitors: Under investigation for adenomyosis treatment 5, 4

Minimally Invasive Procedures

When medical management fails or is contraindicated:

  • Uterine Artery Embolization (UAE): Usually appropriate for reproductive-age patients with concurrent adenomyosis and fibroids who have no desire for future fertility 1

    • Improves symptom scores and quality of life
    • Shorter hospital stay compared to hysterectomy
    • Note: 20-25% incidence of symptom recurrence at 5-7 years 2
  • MR-guided Focused Ultrasound (MRgFUS): Uses high-intensity ultrasound waves to thermally ablate lesions 2, 6

  • Radiofrequency Ablation (RFA): May be proposed when medical therapy is ineffective 6

  • Hysteroscopic procedures: May be considered in selected cases 6

Surgical Management

When other treatments fail or for definitive treatment:

  • Conservative surgical approaches:

    • Cytoreductive surgery (adenomyomectomy)
    • Effective for improving abnormal uterine bleeding, pelvic pain, and reducing uterine volume
    • Caution: Should be performed by experienced surgeons in dedicated centers 6
    • Note: Associated with post-operative risks and potential obstetric complications
  • Hysterectomy: The only definitive treatment for adenomyosis 6, 7

    • Very high patient satisfaction (90% reporting at least moderate satisfaction 2 years after procedure) 2
    • Completely eliminates risk of recurrence

Treatment Algorithm

  1. Initial presentation: Start with medical management

    • For pain predominant: NSAIDs → hormonal options
    • For bleeding predominant: Tranexamic acid → hormonal options
    • Levonorgestrel IUD is particularly effective for long-term management
  2. If medical management fails:

    • For patients desiring fertility: Consider GnRH agonists (short-term)
    • For patients not desiring fertility: Consider UAE or other minimally invasive procedures
  3. If minimally invasive procedures fail:

    • For patients desiring fertility: Conservative surgical approaches by experienced surgeons
    • For patients not desiring fertility: Hysterectomy for definitive treatment

Important Considerations

  • No drug is currently FDA-approved specifically for adenomyosis 5
  • Symptoms often recur after discontinuation of medical therapy 3
  • Treatment selection should consider:
    • Symptom severity (pain vs. bleeding)
    • Patient's age
    • Fertility desires
    • Uterine size
    • Economic considerations 3
  • Conservative surgical treatments require specialized expertise and carry risks of complications 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Uterine Fibroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Progress on medical treatment in the management of adenomyosis].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2019

Research

Adenomyosis: a systematic review of medical treatment.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2016

Research

Conservative surgical treatment for adenomyosis: New options for looking beyond uterus removal.

Best practice & research. Clinical obstetrics & gynaecology, 2024

Research

Pathology and physiopathology of adenomyosis.

Best practice & research. Clinical obstetrics & gynaecology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.